Advertisement

Topics

EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.

2017-02-20 13:49:46 | BioPortfolio

Published on BioPortfolio: 2017-02-20T13:49:46-0500

Clinical Trials [1847 Associated Clinical Trials listed on BioPortfolio]

Fenzian Asthma Multicenter Outcomes Study

The purpose of this study is to investigate the effects of Fenzian™ treatment on symptoms (such as shortness of breath), lung function (how well the lungs work), and albuterol/salbutamol...

A 3-Week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

This study is designed to investigate the ability of patients with asthma to properly use a new multi-dose dry powder inhaler (MDDPI) device in a real-life situation.

Description of the Ability to Learn How to Handle Inhaler Devices in Asthma

Asthma is a major public health problem. The main treatments against asthma are delivered to the lung through several dry-powder inhaler such as Turbuhaler ®, Diskus® and the new Ellipta...

Use of High Frequency Chest Compression in Pediatric Status Asthmaticus

Asthma is a disease resulting in mucus hypersecretion and airways obstruction. This causes difficulty breathing. The High Frequency Chest Compressor (HFCC) is a device that has been shown ...

Impact of Adult Asthma

To assess the separate and interactive effects of asthma severity, subspecialty practice variation, asthma-related psychosocial variables, and other factors on asthma outcomes, including a...

PubMed Articles [3143 Associated PubMed Articles listed on BioPortfolio]

Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD.

Inhaled medications are the cornerstone of treatment and management of asthma and COPD. However, inhaler device errors are common among patients and have been linked with reduced symptom control, an i...

ASTHMA PATIENT SATISFACTION WITH DIFFERENT DRY POWDER INHALERS.

The preferences and opinions of patients are important when choosing the optimal inhaler device for asthma management. We compared patient satisfaction of three dry powder inhalers in patients with mo...

What is New in the Management of Childhood Asthma?

Asthma still causes considerable morbidity and mortality globally and minimal improvement has been seen in key outcomes over the last decade despite increasing treatment costs. This review summarizes ...

Update: Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma.

Favorable response to asthma-dosed subcutaneous mepolizumab in eosinophilic pneumonia.

Mepolizumab targets eosinophils in the treatment of asthma. The dose used for asthma is considerably lower than that used for treating eosinophilic granulomatosis with polyangiitis, a recently approve...

Medical and Biotech [MESH] Definitions

Removal of a MEDICAL DEVICE from the market due to the identification of an intrinsic property of the device that results in a serious risk to public health.

Asthma attacks caused, triggered, or exacerbated by OCCUPATIONAL EXPOSURE.

Device designed to wear externally to support muscular skeletal system in various movements such as RANGE OF MOTIONS; WEIGHT-BEARING; GAIT; and LOCOMOTION.

Removal of a MEDICAL DEVICE from the market due to a problem occurring in the manufacture or distribution of the product.

The shifting in position or location of an INTRAUTERINE DEVICE from its original placement.

More From BioPortfolio on "EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study."

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial